Diagnosis of Crohn's disease and ulcerative colitis using the microbiome/Experiment 3

From BugSigDB


Reviewed Marked as Reviewed by ChiomaBlessing on 2024-3-23

Curated date: 2024/03/09

Curator: Samreen-19

Revision editor(s): Samreen-19, ChiomaBlessing

Subjects

Location of subjects
South Korea
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Gut microbiome measurement Gut microbiome measurement,gut microbiome measurement
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Ulcerative colitis (UC) patients
Group 1 name Corresponds to the case (exposed) group for case-control studies
Crohn's disease (CD) patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with Crohn's disease
Group 0 sample size Number of subjects in the control (unexposed) group
198
Group 1 sample size Number of subjects in the case (exposed) group
69
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
None.

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
MGISEQ-2000

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Linear Regression
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.0001
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes

Alpha Diversity

Chao1 Abundance-based estimator of species richness
decreased

Signature 1

Reviewed Marked as Reviewed by ChiomaBlessing on 2024-3-23

Curated date: 2024/03/09

Curator: Samreen-19

Revision editor(s): Samreen-19, ChiomaBlessing

Source: Supplemental. file: Table S2

Description: Differences in the taxonomic composition of the gut microbiome in patients with Crohn's disease (CD) compared to Ulcerative colitis (UC)

Abundance in Group 1: increased abundance in Crohn's disease (CD) patients

NCBI Quality ControlLinks
Citrobacter werkmanii
Escherichia albertii
Escherichia coli
Escherichia fergusonii
Escherichia marmotae
Salmonella enterica
Shigella dysenteriae
Shigella flexneri
Enterobacteriaceae bacterium strain FGI 57

Revision editor(s): Samreen-19, ChiomaBlessing

Signature 2

Reviewed Marked as Reviewed by ChiomaBlessing on 2024-3-23

Curated date: 2024/03/09

Curator: Samreen-19

Revision editor(s): Samreen-19, ChiomaBlessing

Source: Supplemental. file: Table S2

Description: Differences in the taxonomic composition of the gut microbiome in patients with Crohn's disease (CD) compared to Ulcerative colitis (UC)

Abundance in Group 1: decreased abundance in Crohn's disease (CD) patients

NCBI Quality ControlLinks
Faecalibacterium prausnitzii
Lachnospira eligens
Ligilactobacillus ruminis
Alicycliphilus denitrificans
Stigmatella aurantiaca

Revision editor(s): Samreen-19, ChiomaBlessing